Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease patients and low bodyweight: results from KNOW-CKD study

Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease patients and low bodyweight: results from KNOW-CKD study

Abstract The benefits and risks of aspirin therapy for patients with chronic kidney disease (CKD) who have a high burden of cardiovascular events (CVE) are controversial. To examine the effects of low-dose aspirin on major clinical outcomes in patients with CKD. As a prospective observational cohort...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yun Jung Oh, Ae Jin Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Young Youl Hyun, Joongyub Lee, Yeong Hoon Kim, Seung Hyeok Han, Dong-Wan Chae, Curie Ahn, Kook-Hwan Oh, Ji Yong Jung
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/6639d5a845fc4c3894accb1a26f1bfe1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/6639d5a845fc4c3894accb1a26f1bfe1

Ejemplares similares